Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$232.35 -5.93 (-2.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) EBITDA (2010 - 2026)

Updated

Jazz Pharmaceuticals' EBITDA was $427.3 million in Q2 2026, compared with -$512.4 million a year earlier and down 17.5% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) EBITDA (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Jazz Pharmaceuticals' EBITDA was $1.61 billion through Jun 30, 2026, up 323.7% year-over-year; for FY2025, it was $266.06 million, down 80.7% from FY2024.

  • EBITDA shows a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
  • In earlier years, EBITDA was $1.38 billion in FY2024 (+13.1%), $1.22 billion in FY2023 (+115.9%), $563.94 million in FY2022 (-22.0%) and $722.76 million in FY2021 (+10.1%).
  • Quarterly EBITDA has moved between -$512.4 million (Q2 2025) and $518 million (Q1 2026) over five years.
  • Compared with a year earlier, EBITDA was higher in four of the last six quarters, with growth averaging 59.0%.
  • The best year-over-year quarter for EBITDA over five years was Q1 2026 (growth of 375.7%); the worst was Q1 2025 (a decline of 52.6%).
  • Per Business Quant data, JAZZ's EBITDA in the three quarters before Q2 2026 was $518 million (Q1 2026), $433.7 million (Q4 2025) and $235.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Jazz Pharmaceuticals 15.47 Bn 9.29 Bn 1.09 Bn 427.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 427.30 Mn
Mar 31, 2026 518.00 Mn
Dec 31, 2025 433.70 Mn
Sep 30, 2025 235.79 Mn
Jun 30, 2025 -512.40 Mn
Mar 31, 2025 108.90 Mn
Dec 31, 2024 359.19 Mn
Sep 30, 2024 425.44 Mn
Jun 30, 2024 362.48 Mn
Mar 31, 2024 229.59 Mn
Dec 31, 2023 281.70 Mn
Sep 30, 2023 334.95 Mn
Jun 30, 2023 317.21 Mn
Mar 31, 2023 283.42 Mn
Dec 31, 2022 -118.66 Mn
Sep 30, 2022 173.59 Mn
Jun 30, 2022 241.75 Mn
Mar 31, 2022 267.26 Mn
Dec 31, 2021 214.00 Mn
Sep 30, 2021 195.95 Mn
API Access

Jazz Pharmaceuticals EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=JAZZ&period=max&api_key=YOUR_API_KEY